Toggle Sidebar
Home
AI Agent
Annotations
Watchlists
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
IBRX US
ImmunityBio, Inc.
(IBRX US)
$8.22
-0.09
1.08%
Ext:
$8.24
+0.02
0.25%
(Market Closed · 23:56:40 UTC)
Follow
Chronological SEC Filings
Select Filings
Ask in Filing
Non-Ownership Filings
(264)
Expand
8-K
FDA Expands ANKTIVA®Approval forBCG-UnresponsiveNon-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease
14 Oct
10-Q
Q2
ended 30 Jun 2026
4 Aug
8-K
Results of Operations and Financial Condition
4 Aug
8-K
Regulation FD Disclosure
30 Jul
8-K
Submission of Matters to a Vote of Security Holders
10 Jun
8-K
ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States
18 May
10-Q
Q1
ended 31 Mar 2026
7 May
8-K
Results of Operations and Financial Condition
7 May
DEFA14A
Definitive additional materials
29 Apr
DEF 14A
Definitive proxy statement
29 Apr
ARS
Annual report to security holders
29 Apr
8-K
Results of Operations and Financial Condition
9 Apr
8-K
ImmunityBio Addresses FDA Correspondence and Reaffirms Commitment to Advertising Compliance
6 Apr
8-K
ImmunityBio Strengthens Balance Sheet with $100 Million of Financing Transactions Including $75 Million ofNon-DilutiveFinancing to Support Global Expansion and Advancement of Broader Immunotherapy Pipeline
31 Mar
10-K
FY 2025
ended 31 Dec 2025
23 Feb
8-K
Results of Operations and Financial Condition
23 Feb
8-K
Other Events
18 Feb
8-K
Entry into a Material Definitive Agreement
26 Jan
8-K
Results of Operations and Financial Condition
15 Jan
8-K
Other Events
14 Jan
Ownership Filings
(281)
Expand
4
Statement of changes in beneficial ownership
6 Oct
4
Statement of changes in beneficial ownership
6 Oct
144
Simon Barry J.
5 Oct
144
Cohen Cheryl
2 Oct
SC 13D/A
ImmunityBio, Inc.
6 Aug
4
Statement of changes in beneficial ownership
6 Jul
4
Statement of changes in beneficial ownership
6 Jul
144
Cohen Cheryl
2 Jul
4
Statement of changes in beneficial ownership
1 Jul
144
Selecky Christobel
1 Jul
144
Selecky Christobel
30 Jun
144
Selecky Christobel
29 Jun
4
Statement of changes in beneficial ownership
26 Jun
4
Statement of changes in beneficial ownership
10 Jun
4
Statement of changes in beneficial ownership
10 Jun
4
Statement of changes in beneficial ownership
10 Jun
4
Statement of changes in beneficial ownership
10 Jun
4
Statement of changes in beneficial ownership
10 Jun
4
Statement of changes in beneficial ownership
10 Jun
4
Statement of changes in beneficial ownership
5 Jun
Financials & Metrics
Financials
Charting
Short Interest
Employees
